Contagious diseases persist as a formidable challenge in the 21st century, marked by both enduring threats and emerging complexities. Antimicrobial resistance (AMR) poses a looming crisis, diminishing the efficacy of antibiotics and antimicrobial drugs. Addressing AMR requires a multifaceted approach, including responsible antibiotic use, development of novel therapies, and global cooperation to combat the spread of drug-resistant pathogens. The digital age brings new dimensions to the management of contagious diseases, with innovations such as telemedicine, digital surveillance, and big data analytics playing pivotal roles. These technologies enhance early detection, monitoring, and response capabilities, providing valuable tools in the fight against outbreaks. Additionally, the rapid development and deployment of mRNA vaccines during the COVID-19 pandemic highlight the potential for groundbreaking advancements in vaccine technologies, offering hope for future infectious disease challenges. Vector-borne diseases, facilitated by climate change and increased global travel, continue to pose significant threats. Diseases like Zika, dengue, and Lyme disease emphasize the need for novel vector control strategies, research into new therapeutics, and public health education to mitigate the impact of these diseases on vulnerable populations.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain